SIRT4 and Hepatic fibrosis: In liver fibrosis, SIRT4 enhances the cytotoxicity of natural killer cells toward activated hepatic stellate cells by activating the AMPKα/P-p53/NKG2DL pathway, thereby reversing fibrosis [105].